AC Immune (ACIU) Depreciation and Depletion (2014 - 2025)
AC Immune (ACIU) posted quarterly Depreciation and Depletion of $411634.9 for Q4 2025, little changed year-over-year from $409806.3 in Q4 2024, and down 3.15% quarter-over-quarter from $425037.2 in Q3 2025.
AC Immune (ACIU) Depreciation and Depletion (2014 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Depreciation and Depletion for 12 consecutive years, with $411634.9 the latest figure, recorded in Q4 2025.
- In Q4 2025, Depreciation and Depletion changed 0.45% year-over-year to $411634.9; the TTM figure through Dec 2025 stood at $1.7 million (down 0.66% YoY), while the FY2025 annual figure was $1.7 million, down 0.89% from the prior year.
- Depreciation and Depletion retreated to $411634.9 in Q4 2025 per ACIU's latest filing, from $425037.2 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $539118.9 in Q3 2021 and bottomed at $401522.4 in Q1 2025.
- Historically, Depreciation and Depletion has averaged $459036.8 across 5 years, with a median of $452536.6 in 2022.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion surged 37.14% — and 2022, when it dropped 15.88%.
- AC Immune's Depreciation and Depletion stood at $527068.0 in 2021, then retreated by 9.01% to $479566.1 in 2022, then fell by 1.97% to $470106.8 in 2023, then retreated by 12.83% to $409806.3 in 2024, then climbed by 0.45% to $411634.9 in 2025.
- Business Quant data shows ACIU's Depreciation and Depletion at $411634.9 in Q4 2025, $425037.2 in Q3 2025, and $438464.2 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 411,634.86 |
| Dec 31, 2025 | 411,634.86 |
| Sep 30, 2025 | 425,037.23 |
| Sep 30, 2025 | 425,037.23 |
| Jun 30, 2025 | 438,464.15 |
| Jun 30, 2025 | 438,464.15 |
| Mar 31, 2025 | 401,522.44 |
| Mar 31, 2025 | 401,522.44 |
| Dec 31, 2024 | 409,806.34 |
| Dec 31, 2024 | 409,806.34 |
| Sep 30, 2024 | 414,360.40 |
| Sep 30, 2024 | 414,360.40 |
| Jun 30, 2024 | 417,989.94 |
| Jun 30, 2024 | 417,989.94 |
| Mar 31, 2024 | 445,670.42 |
| Mar 31, 2024 | 445,670.42 |
| Dec 31, 2023 | 470,106.82 |
| Dec 31, 2023 | 470,106.82 |
| Sep 30, 2023 | 467,579.01 |
| Sep 30, 2023 | 467,579.01 |